Forsta AP Fonden Sells 24,380 Shares of HCA Healthcare, Inc. $HCA

Posted by Geri Gentry on May 31st, 2026

Forsta AP Fonden decreased its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 42.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,420 shares of the company’s stock after selling 24,380 shares during the period. Forsta AP Fonden’s holdings in HCA Healthcare were worth $15,602,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares during the period. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after acquiring an additional 33 shares during the last quarter. Jump Financial LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth approximately $2,073,000. Finally, Sei Investments Co. lifted its stake in HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Price Performance

NYSE HCA opened at $377.72 on Friday. The stock has a market capitalization of $83.79 billion, a PE ratio of 12.99, a P/E/G ratio of 1.20 and a beta of 1.18. HCA Healthcare, Inc. has a 1 year low of $330.00 and a 1 year high of $556.52. The company’s 50 day simple moving average is $451.94 and its two-hundred day simple moving average is $480.74.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the business posted $6.45 EPS. The company’s quarterly revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is currently 10.73%.

Wall Street Analyst Weigh In

HCA has been the topic of several research reports. Mizuho boosted their target price on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Robert W. Baird cut their price objective on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Finally, Argus dropped their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.

Read Our Latest Report on HCA Healthcare

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.